FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080484450> ?p ?o ?g. }

• W2080484450 endingPage "86" @default.
• W2080484450 startingPage "78" @default.
• W2080484450 abstract "Protease inhibitors (PI) with peginterferon/ribavirin have significantly improved SVR rates in HCV G1 patients. Their use to treat HCV recurrence after liver transplantation (LT) is a challenge.This cohort study included 37 liver transplant recipients (male, 92%, age 57 ± 11 years), treated with boceprevir (n=18) or telaprevir (n=19). The indication for therapy was HCV recurrence (fibrosis stage ≥F2 (n=31, 83%) or fibrosing cholestatic hepatitis (n=6, 16%).Eighteen patients were treatment-naive, five were relapsers and fourteen were non-responders to dual therapy after LT. Twenty-two patients received cyclosporine and fifteen tacrolimus. After 12 weeks of PI therapy, a complete virological response was obtained in 89% of patients treated with boceprevir, and 58% with telaprevir (p=0.06). The end of treatment virological response rate was 72% (13/18) in the boceprevir group and 40% (4/10) in the telaprevir group (p=0.125). A sustained virological response 12 weeks after treatment discontinuation was observed in 20% (1/5) and 71% (5/7) of patients in the telaprevir and boceprevir groups, respectively (p=0.24). Treatment was discontinued in sixteen patients (treatment failures (n=11), adverse events (n=5)). Infections occurred in ten patients (27%), with three fatal outcomes (8%). The most common adverse effect was anemia (n=34, 92%), treated with erythropoietin and/or a ribavirin dose reduction; thirteen patients (35%) received red blood cell transfusions. The cyclosporine dose was reduced by 1.8 ± 1.1-fold and 3.4 ± 1.0-fold with boceprevir and telaprevir, respectively. The tacrolimus dose was reduced by 5.2 ± 1.5-fold with boceprevir and 23.8±18.2-fold with telaprevir.Our results suggest that triple therapy is effective in LT recipients, particularly those experiencing a severe recurrence. The occurrence of anemia and drug-drug interactions, and the risk of infections require close monitoring." @default.
• W2080484450 created "2016-06-24" @default.
• W2080484450 creator A5007474830 @default.
• W2080484450 creator A5014381368 @default.
• W2080484450 creator A5016176669 @default.
• W2080484450 creator A5037714118 @default.
• W2080484450 creator A5038280651 @default.
• W2080484450 creator A5044905145 @default.
• W2080484450 creator A5052064056 @default.
• W2080484450 creator A5054436603 @default.
• W2080484450 creator A5059508363 @default.
• W2080484450 creator A5061550504 @default.
• W2080484450 creator A5077991993 @default.
• W2080484450 creator A5086666166 @default.
• W2080484450 creator A5088674104 @default.
• W2080484450 creator A5091564657 @default.
• W2080484450 date "2014-01-01" @default.
• W2080484450 modified "2023-10-18" @default.
• W2080484450 title "Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience" @default.
• W2080484450 cites W1483770573 @default.
• W2080484450 cites W1545862634 @default.
• W2080484450 cites W1965358723 @default.
• W2080484450 cites W1979175722 @default.
• W2080484450 cites W1985395902 @default.
• W2080484450 cites W1989766145 @default.
• W2080484450 cites W2005082679 @default.
• W2080484450 cites W2005946395 @default.
• W2080484450 cites W2016940336 @default.
• W2080484450 cites W2022234824 @default.
• W2080484450 cites W2026951503 @default.
• W2080484450 cites W2029944598 @default.
• W2080484450 cites W2036646541 @default.
• W2080484450 cites W2038800845 @default.
• W2080484450 cites W2043067438 @default.
• W2080484450 cites W2046658390 @default.
• W2080484450 cites W2061099562 @default.
• W2080484450 cites W2079728952 @default.
• W2080484450 cites W2091664007 @default.
• W2080484450 cites W2094174828 @default.
• W2080484450 cites W2095570476 @default.
• W2080484450 cites W2105166177 @default.
• W2080484450 cites W2117134469 @default.
• W2080484450 cites W2124882260 @default.
• W2080484450 cites W2125963799 @default.
• W2080484450 cites W2128390124 @default.
• W2080484450 cites W2141214317 @default.
• W2080484450 cites W2141404639 @default.
• W2080484450 cites W2143559032 @default.
• W2080484450 cites W2154690931 @default.
• W2080484450 cites W2155520529 @default.
• W2080484450 doi "https://doi.org/10.1016/j.jhep.2013.08.018" @default.
• W2080484450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23994384" @default.
• W2080484450 hasPublicationYear "2014" @default.
• W2080484450 type Work @default.
• W2080484450 sameAs 2080484450 @default.
• W2080484450 citedByCount "177" @default.
• W2080484450 countsByYear W20804844502013 @default.
• W2080484450 countsByYear W20804844502014 @default.
• W2080484450 countsByYear W20804844502015 @default.
• W2080484450 countsByYear W20804844502016 @default.
• W2080484450 countsByYear W20804844502017 @default.
• W2080484450 countsByYear W20804844502018 @default.
• W2080484450 countsByYear W20804844502019 @default.
• W2080484450 countsByYear W20804844502020 @default.
• W2080484450 countsByYear W20804844502021 @default.
• W2080484450 countsByYear W20804844502022 @default.
• W2080484450 countsByYear W20804844502023 @default.
• W2080484450 crossrefType "journal-article" @default.
• W2080484450 hasAuthorship W2080484450A5007474830 @default.
• W2080484450 hasAuthorship W2080484450A5014381368 @default.
• W2080484450 hasAuthorship W2080484450A5016176669 @default.
• W2080484450 hasAuthorship W2080484450A5037714118 @default.
• W2080484450 hasAuthorship W2080484450A5038280651 @default.
• W2080484450 hasAuthorship W2080484450A5044905145 @default.
• W2080484450 hasAuthorship W2080484450A5052064056 @default.
• W2080484450 hasAuthorship W2080484450A5054436603 @default.
• W2080484450 hasAuthorship W2080484450A5059508363 @default.
• W2080484450 hasAuthorship W2080484450A5061550504 @default.
• W2080484450 hasAuthorship W2080484450A5077991993 @default.
• W2080484450 hasAuthorship W2080484450A5086666166 @default.
• W2080484450 hasAuthorship W2080484450A5088674104 @default.
• W2080484450 hasAuthorship W2080484450A5091564657 @default.
• W2080484450 hasConcept C126322002 @default.
• W2080484450 hasConcept C197934379 @default.
• W2080484450 hasConcept C203014093 @default.
• W2080484450 hasConcept C2522874641 @default.
• W2080484450 hasConcept C2776408679 @default.
• W2080484450 hasConcept C2776455275 @default.
• W2080484450 hasConcept C2777159539 @default.
• W2080484450 hasConcept C2778159067 @default.
• W2080484450 hasConcept C2778715236 @default.
• W2080484450 hasConcept C2779609443 @default.
• W2080484450 hasConcept C2780040827 @default.
• W2080484450 hasConcept C2911091166 @default.
• W2080484450 hasConcept C71924100 @default.
• W2080484450 hasConcept C90924648 @default.
• W2080484450 hasConceptScore W2080484450C126322002 @default.
• W2080484450 hasConceptScore W2080484450C197934379 @default.

• next